The efficacy of ginger for the prevention of postoperative nausea and vomiting was studied in a double-blind, randomized, controlled trial in J08 ASA 1 or 2 patients undergoing gynaecologicallaparoscopic surgery under general anaesthesia. Patients received oral placebo, ginger BP 0.5g or ginger BP l.Og, all with oral diazepam premedication, one hour prior to surgery. Patients were assessed at three hours postoperatively. The incidence of nausea and vomiting increased slightly but nonsignijicantly with increasing dose of ginger. The incidence of moderate or severe nausea was 22, 33 and 36%, while the incidence of vomiting was 17, 14 and 31% in groups receiving 0, 0.5 and 1.0g ginger, respectively (odds ratio per 0.5g ginger 1.39 for nausea and 1.55 for vomiting). These results were essentially unchanged when adjustment was made for concomitant risk factors. We conclude that ginger BP in doses of 0.5 or 1.0 gram is ineffective in reducing the incidence of postoperative nausea and vomiting.
The incidence of postoperative nausea and vomiting has been estimated to be between 300/0 and 50%1-4. It has remained at this level for decades despite a number of promising new therapeutic agents. Factors believed to be associated with this unpleasant side-effect of surgery and anaesthesia are patient's age, body weight, gender, previous postoperative nausea and vomiting, predisposition to motion sickness and phase of the menstrual cycle 5 -7
• Despite the potential of other techniques such as acupuncture 8 , drugs remain the mainstay of therapy to alleviate patient discomfort and to minimize the risks of dehydration, electrolyte disturbance, aspiration, oesophageal injury, and wound breakdown.
The use of anti nauseant drugs prophylactically has been argued, but with no definite conclusion, at least partly because of the side-effects of drugs 6 • Ginger root (Zingiber officinale Roscoe) has been reported to be useful in the prevention of motion sickness lO • 1I and in the treatment of hyperemesis gravidarum l2 and migraine l3 . Recently ginger has been reported to be as effective as metoclopramide and better than placebo for the prevention of postoperative nausea and vomiting following both major surgeryl4 and day care surgeryl5. Ginger has few recorded side-effects. Very large doses of ginger may increase gastric exfoliation l6 and anti prostaglandin activity has been demonstrated in vitro 17 -19 , but the clinical significance of these observations has yet to be determined.
With the potential for ginger to provide an alternative to currently available drugs as prophylaxis for postoperative nausea and vomiting, possibly with fewer side-effects and high patient acceptability, we considered further investigation of dose and efficacy were warranted.
MATERIALS AND METHODS
A randomized, double-blind, placebo controlled study was approved by the Hospital Ethics Committee. Informed and written consent was obtained from each patient.
Sample size was determined to provide 80% power to detect a reduction in incidence of nausea from 30% to 20% associated with an increase in ginger dose of 0.5g, with a type I error of 0.05. This led to a requirement for a total of 108 patients 20 • Patients scheduled for elective gynaecological laparoscopic surgery, ASA I or 2 and aged between 18 and 75 years were eligible for entry to the study. Patients with known allergy to ginger or intolerance to spicy foods, who were pregnant or lactating or receiving other antiemetic treatment, were excluded from the study. Capsules containing 500 mg of ginger powder BP 1988 (Zingiber officinale) or placebo (cellulose-microcrystalline, BP 1988) were supplied by Blackmores Ltd (Sydney, Australia). It was found necessary to use opaque black capsules so that the different colours of the ginger and placebo powders were not evident. When initially supplied, the ginger capsules could be identified by their smell. It was found that after storage of the capsules in pairs in small polyethylene bags for two days the smell disappeared and ginger and placebo capsules could not be distinguished by a panel of volunteers. Therefore all capsules were prepackaged in this way prior to being coded and supplied to the investigators by the pharmacy. All patients received diazepam 10 mg as oral premedication plus two study medication capsules. Patients were randomly allocated to one of three groups:
Group 1 received two placebo capsules; Group 2 received one placebo and one ginger capsule (500 mg ginger); Group 3 received two ginger capsules (total of 1000 mg ginger). The diazepam tablets and study capsules were administered with 20-30 ml of water one hour before induction of anaesthesia.
Anaesthesia was induced using thiopentone 4-5 mg/kg followed by vecuronium 0.1 mg/kg. After intubation, the lungs were ventilated with 66070 N 2 0 and 1% enflurane in oxygen. lntraoperative analgesia was provided by intravenous doses of morphine. No antiemetics were given intraoperatively. All laparoscopic procedures were carried out with the patient in the lithotomy position. At the end of surgery neuromuscular block was reversed with atropine and neostigmine. Postoperatively patients were transferred to the recovery area and cared for until fit to return to the ward. Recovery ward nursing staff were unaware of the nature of the preoperative study medication. Postoperative pain was treated by administering small intravenous doses of morphine (1-2 mg) as required. Metoclopramide, 10 mg IV, was prescribed to be given only if the patient experienced severe nausea or vomited. Three hours postoperatively patients were directly questioned by one of the investigators (who was blinded to the treatment received) to determine whether they had experienced any nausea or vomiting since regaining consciousness. The three-hour time point was chosen for assessment because most (63%) of the patients were day patients who were generally discharged by four hours. Where present, nausea was graded into three categories of severity, giving four categories in all: 0= no nausea 1 = mild nausea 2 = moderate nausea 3 = severe nausea or patient given antiemetic medication for nausea. Vomiting was categorized as:
Vomiting at the time of extubation was not considered to be postoperative vomiting for the purpose of this study. Patients were then directly asked about any side-effects which might have been caused by the capsules. If they answered "yes", they were further questioned to determine the nature of the complaint.
The influence of ginger on the incidence of nausea and vomiting was examined by logistic regression 21 • For purposes of this analysis, nausea was deemed to be absent if reported as "no nausea" or "mild nausea" and present if reported as "moderate" or "severe". Explanatory variables examined included dose of ginger (coded as 0, 1 and 2 for 0,500 mg and 1000 mg doses), history of previous postoperative nausea (0 = no, 1 = yes), reported tendency to motion sickness (0 = no, 1 = yes), days since last menstrual period, coded as two dummy variables, contrasting ovulatory (days 9 to 16) and postovulatory phases (days 17 + ), with preovulatory phase (days 1-8), and amount of morphine received. Age of patient was categorized as under 30 years (coded zero) or 30 years or greater (coded 1). The cut-off of 30 years was chosen because it was near the median age of the patients. Power to detect any effect of age is greatest when numbers of patients in the two age categories are similar.
Nausea severity score was examined in a similar manner l'sing regression analysis.
RESULTS
Six patients who entered the study were excluded due to cancellation of their operation (n = 1), change in the type of operation (n = 2), premedication being given less than one hour prior to the operation (n = 2) or because fentanyl was given intraoperatively (n = 1). Additional patients were recruited to replace these.
Despite the characteristic taste and smell of ginger, blinding was substantially maintained in this study. Only one patient claimed to know whether she had received ginger or placebo. This patient reported having been able to taste ginger between the time of administration of the capsules and the time of assessment. On breaking the code after completion of the study she was found to have received ginger 0.5g. Demographic data were similar for the three treatment groups (Table 1) . No patient received any morphine after return to the ward but before assessment. Amount of morphine received intraoperatively and in recovery were summed for use as a covariate ("total morphine" in Table 1 ). The overall incidence of postoperative nausea was 31070 and vomiting 20%. The incidence of nausea and vomiting tended to increase as dose of ginger increased from 0 to LOg (Table 2) , however this trend was not statistically significant (unadjusted odds ratio for nausea = 1.39 per 0.5g ginger, P = 0.2, and odds ratio for vomiting = 1.55, P = 0.15). Following adjustment for history of postoperative nausea, tendency to motion sickness, phase of menstrual cycle, age and total amount of morphine received, dose of ginger was stilI not significantly associated with incidence of nausea (P = 0.36) or vomiting (P = 0.34). Analyses involving covariance adjustment for phase of the menstrual cycle were based on 102 patients as this variable was missing in six cases. None of the covariates was significantly associated with incidence of vomiting (P>0.10), but both history of postoperative nausea and tendency to motion sickness were positively associated with incidence of postoperative nausea, while age showed a negative association. Table 3 shows odds ratios for the influence of ginger and other potential risk factors on the incidence of postoperative nausea, adjusted for the effects of all other listed factors. The distribution of nausea severity scores is given in Table 4 . When these scores were used as the dependent variable in regression analysis, similar results were obtained to those obtained by logistic regression analysis of the incidence of nausea. Nausea score was not significantly associated with dose of ginger (P = 0.47) and this conclusion was unaltered by inclusion of history of postoperative nausea, tendency to motion sickness, phase of menstrual cycle, age or amount of morphine received as covariates. Possible adverse effects were observed in six patients. One of these, who complained of feeling windy and having an urge to burp, was in the placebo group. Two had received 0.5g of ginger, one complained of flatulence and a bloated feeling while the other complained of heartburn. The remaining three had all received 19 of ginger. One complained of severe heartburn after swallowing the capsules, one felt nauseous after swallowing the capsules, while the third complained of burping.
DISCUSSION
The study shows that ginger powder BP in doses of 0.5 or 1.0g is ineffective in preventing postoperative nausea and vomiting. In fact, the incidence of nausea and vomiting tended to increase as dose of ginger increased from 0 to l.Og, but this trend was not statistically significant. These results fail to support conclusions of some previous reports which suggested beneficial effects of ginger for preventing postoperative nausea and vomiting. Bone et all' compared ginger with placebo and with metoclopramide following major gynaecological surgery. Incidence and severity of nausea were not significantly different among the groups. Furthermore the incidence of "failed treatments", that is, the occurrence of any emetic sequelae at any time, was not significantly different between ginger (9120) and placebo (14120). The purported beneficial effects of ginger appear to have been primarily inferred from differences in numbers of incidents of nausea (23 incidents in 20 patients following ginger, 41 incidents in 20 patients following placebo). It is unclear how these non-independent data were analysed to conclude that a significant difference existed.
Phillips et aliI reported the effects of ginger on nausea and vomiting following laparoscopic surgery. There were important differences in methodology between their study and ours; in particular in their study anaesthesia was induced with propofol, an agent having antiemetic effects, and postoperative analgesia was not standardized; some patients received no analgesic agent postoperatively while others received paracetamol, paracetamol plus dihydrocodeine, or pethidine. Furthermore, the mean age of patients in the placebo group was 31 years compared to 35 in the ginger group. Our results show age less than 30 years to be a strong risk factor for postoperative nausea. Despite these differences, their results are in agreement with ours in that incidence of nausea (19/40 for ginger, 25/40 for placebo) and vomiting (4/40 for ginger, 9/40 for placebo) did not differ significantly between ginger and placebo groups.
In conclusion we have demonstrated that ginger powder BP in doses of 0.5 or 1.0g does not reduce the incidence of postoperative nausea and vomiting. Our results confirm that a history of postoperative nausea and vomiting and of motion sickness are important risk factors for postoperative nausea and vomiting.
